Cargando…
E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081993/ https://www.ncbi.nlm.nih.gov/pubmed/37029121 http://dx.doi.org/10.1038/s41408-023-00828-4 |
| _version_ | 1785021224950169600 |
|---|---|
| author | Maksimos, Mina Muz, Barbara Magnani, John L. Azab, Abdel Kareem |
| author_facet | Maksimos, Mina Muz, Barbara Magnani, John L. Azab, Abdel Kareem |
| author_sort | Maksimos, Mina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10081993 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100819932023-04-09 E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma Maksimos, Mina Muz, Barbara Magnani, John L. Azab, Abdel Kareem Blood Cancer J Correspondence Nature Publishing Group UK 2023-04-07 /pmc/articles/PMC10081993/ /pubmed/37029121 http://dx.doi.org/10.1038/s41408-023-00828-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Maksimos, Mina Muz, Barbara Magnani, John L. Azab, Abdel Kareem E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma |
| title | E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma |
| title_full | E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma |
| title_fullStr | E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma |
| title_full_unstemmed | E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma |
| title_short | E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma |
| title_sort | e-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081993/ https://www.ncbi.nlm.nih.gov/pubmed/37029121 http://dx.doi.org/10.1038/s41408-023-00828-4 |
| work_keys_str_mv | AT maksimosmina eselectintargetinglipidnanoparticlesimprovetherapeuticefficacyandreducesideeffectsofbortezomibinmultiplemyeloma AT muzbarbara eselectintargetinglipidnanoparticlesimprovetherapeuticefficacyandreducesideeffectsofbortezomibinmultiplemyeloma AT magnanijohnl eselectintargetinglipidnanoparticlesimprovetherapeuticefficacyandreducesideeffectsofbortezomibinmultiplemyeloma AT azababdelkareem eselectintargetinglipidnanoparticlesimprovetherapeuticefficacyandreducesideeffectsofbortezomibinmultiplemyeloma |